Li Kang Biomedical Co., Ltd.

TPEX:6242 Stock Report

Market Cap: NT$1.4b

Li Kang Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6242?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,515,7797.91%
General Public11,302,54135.5%
Private Companies17,988,18056.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.7%.


Top Shareholders

Top 7 shareholders own 64.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.6%
Sheng Chun Tang Pharmaceutical Industrial Co., Ltd.
10,052,437NT$442.3m0%no data
19.2%
Li Kang Biotechnical Co., ltd.
6,103,362NT$268.5m0%no data
4.68%
Top Song Enterprises Co., Ltd.
1,487,390NT$65.4m0%no data
3.6%
Mei-Xun Wang
1,144,253NT$50.3m0%no data
2.3%
Yayi Huang
730,264NT$32.1m0%no data
2.02%
Zhiwen Zheng
641,262NT$28.2m0%no data
1.08%
Hongyu Investment Co., Ltd.
344,991NT$15.2m0%no data